Endo, Inc. — Form D/A
Endo, Inc. of Malvern, PA, a company, filed a Form D amendment with the SEC on 2024-05-06. The offering totals $170.6M, of which $170.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-05-06
- Form: D/A
- Accession: 0000950123-24-003890
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $170.6M
- Amount sold: $170.6M
- Investors: 404
- Date of first sale: 2024-03-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-508269
Issuer
- Name: Endo, Inc.
- CIK: 0002008861
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1400 Atwater Drive, Malvern, PA, 19355
- Phone: (484) 216-0000
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Mark Bradley | Director | South San Francisco, CA |
| Blaise Coleman | Director | Malvern, PA |
| Paul Efron | Director | Malvern, PA |
| Paul Herendeen | Director | Malvern, PA |
| Scott Hirsch | Director | Whippany, NJ |
| Sophia Langlois | Director | Malvern, PA |
| Andy Pasternak | Director | Malvern, PA |
| Marc Yoskowitz | Director | Malvern, PA |
| Patrick Barry | Executive Officer | Malvern, PA |
| Mark Bradley | Executive Officer | South San Francisco, CA |
| Blaise Coleman | Executive Officer | Malvern, PA |
| Matthew Maletta | Executive Officer | St. Louis, MO |
| Frank Raciti | Executive Officer | Malvern, PA |
| Matthew Maletta | Director | St. Louis, MO |
| Deanna Voss | Executive Officer | Malvern, PA |
| Brian Morrissey | Executive Officer | Malvern, PA |
Other filings by this issuer (1)
More